Agency Information Collection Activities: Proposed Collection; Comment Request, 52483-52484 [2024-13766]
Download as PDF
<![CDATA[
52483
Federal Register / Vol. 89, No. 121 / Monday, June 24, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Annual burden hours estimate
Number of
respondents
Form name
Average
burden per
response
(in hours)
Total annual
burden hour
Data and Biospecimen Catalog Submission ...................................................
Institutional Certification Template ..................................................................
Data Request ...................................................................................................
Biospecimen Request ......................................................................................
Data Request Annual Progress Report ...........................................................
Study Catalog Submission ..............................................................................
External Resource Catalog Submission ..........................................................
Data Request Renewal ....................................................................................
36
36
150
4
240
2
4
42
1
1
1
1
1
1
1
1
2
5/60
1
1
30/60
30/60
15/60
10/60
72
3
150
4
120
1
1
7
Total ..........................................................................................................
1,414
1,414
........................
433
Dated: June 17, 2024.
Jennifer M. Guimond,
Project Clearance Liaison, Eunice Kennedy
Shriver National Institute of Child Health and
Human Development, National Institutes of
Health.
[FR Doc. 2024–13715 Filed 6–21–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed project or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at (240) 276–
0166.
Comments are invited on: (a) whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
VerDate Sep<11>2014
18:55 Jun 21, 2024
Jkt 262001
Project: State Opioid Response (SOR)/
Tribal Opioid Response (TOR) Program
Instrument (OMB No. 0930–0384)—
Revision
SAMHSA is requesting approval to
modify its existing SOR/TOR Program
Instrument by (1) broadening language
from ‘naloxone’ to ‘naloxone and other
opioid overdose reversal medications’
due to the availability of new FDAapproved non-naloxone overdose
reversal medications; (2) broadening
language from ‘fentanyl test strips’ to
‘drug checking technologies as directed
by SAMHSA’ due to the availability of
new drug checking technology,
including test strips for other emerging
substances; (3) reducing the number of
questions from 12 to 10 by combining
four questions with similar themes into
two questions for clarity; (4) removing
question 12 because it is comprised of
more than one question with several
different ideas, making it unsuited for
this instrument; and (5) adding one
question at the request of Office of
National Drug Control Policy
(ONDCP)to collect information on
Congressionally mandated and
programmatic activities and comply
with reporting requirements. The
program-level information is collected
quarterly and entered and stored in
SAMHSA’s Performance Accountability
and Reporting System, which is a realtime, performance management system
that captures information on SAMHSA
funded substance use and substance use
disorder prevention, harm reduction,
treatment, and recovery support
services, and mental health services
delivered in the United States.
Continued approval of this information
collection will allow SAMHSA to
continue to meet Government
Performance and Results Modernization
Act (GPRA) of 2010 reporting
requirements that quantify the effects
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
and accomplishments of its
discretionary grant programs.
The SOR/TOR programs are
authorized under the Consolidated
Appropriations Act, 2023, Division H,
Title II [Pub. L. 117–328], and section
1003 of the 21st Century Cures Act [Pub.
L. 114–255] (42 U.S.C. 290ee–3a), as
amended. SOR/TOR programs aim to
address the opioid crisis by increasing
access to FDA-approved medications for
the treatment of opioid use disorder
(MOUD), and support the continuum of
prevention, harm reduction, treatment,
and recovery support services for opioid
use disorder (OUD) and other
concurrent substance use disorders. The
SOR program also supports the
continuum of care for stimulant misuse
and use disorders, including for cocaine
and methamphetamine.
SAMHSA is proposing to revise the
SOR/TOR Program Instrument data
collection instrument (OMB No. 0930–
0384), to collect information on
Congressionally mandated and
programmatic activities and comply
with reporting requirements.
SAMHSA developed the SOR/TOR
Program Instrument to collect minimum
data on naloxone purchase and
distribution, but the SOR/TOR programs
are unique in that they have prevention,
education, and harm reduction
requirements. SOR/TOR grantees are
required to engage in the following
prevention and education activities: (1)
train peers, first responders, and other
key community sectors on recognition
of opioid overdose and appropriate use
of the opioid overdose antidote
naloxone; (2) develop evidence-based
community prevention efforts such as
strategic messaging on the consequences
of opioid and stimulant misuse; (3)
implement school-based prevention
programs and outreach; and (4)
purchase and distribute opioid overdose
antidote reversal naloxone based on the
E:\FR\FM\24JNN1.SGM
24JNN1
52484
Federal Register / Vol. 89, No. 121 / Monday, June 24, 2024 / Notices
naloxone distribution and saturation
plan, and train on its use. The revised
tool will continue to allow SAMHSA to
collect data on the required education
and prevention activities, and better
assess grantee performance on these
activities. The revisions will continue to
assist SAMHSA in providing
comprehensive data on the full range of
required activities to inform
Congressionally mandated reports for
the SOR program.
In order to address these issues,
SAMHSA is proposing to (1) broaden
language from ‘naloxone’ to ‘naloxone
and other opioid overdose reversal
medications’ due to the availability of
new FDA-approved non-naloxone
overdose reversal medications; (2)
broaden language from ‘fentanyl test
strips’ to ‘drug checking technologies as
directed by SAMHSA’ due to the
availability of new drug checking
technology, including test strips for
other emerging substances; (3) reduce
the number of questions from 12 to 10
by combining four questions with
similar themes into two questions for
clarity; (4) remove question 12 because
it is comprised of more than one
question with several different ideas,
making it unsuited for this instrument;
and (5) add one question at the request
of ONDCP to collect information on
Congressionally mandated and
programmatic activities and comply
with reporting requirements.
A summary of the proposed changes
includes:
• Broadening the language to include
new medications and technologies that
will provide SAMHSA data on the
following:
Æ Purchase and distribution of
naloxone and other opioid overdose
reversal medications; and
Æ Purchase and distribution of drug
checking technologies as directed by
SAMHSA.
• The revised tool will provide
SAMHSA with clarification on
individuals recognizing an opioid
overdose and appropriate use of
naloxone and other opioid overdose
reversal medication by collapsing two
questions with a similar theme.
• The revised tool will provide
SAMHSA with clarification on
individuals educated on the
consequences of opioid and/or
stimulant misuse by collapsing two
questions with a similar theme.
• One question will be added to
provide data on the following:
Æ Types of entities that distribute
naloxone and other opioid overdose
reversal medications.
The Center for Substance Abuse
Treatment (CSAT) anticipates that the
time required to collect and report the
program-level information is
approximately 18 minutes per response.
Since the submission of the previous
OMB package, there has been an
increase in the number of respondents.
The estimated burden associated with
the program-level instrument includes
an adjustment to reflect the current
number of grantees.
TABLE 1—ESTIMATE OF ANNUALIZED HOUR BURDEN FOR SOR/TOR GRANTEES
SAMHSA data collection
Number of
respondents
Responses
per
respondent
Total
number of
responses
Burden
hours per
response
Total
burden
hours
Hourly
wage 1
Total
wage
cost
Grantee-Level Instrument ..........................
189
4
756
.30
226.80
$28.89
$6,552.25
CSAT Total ...........
189
4
756
.30
226.80
28.89
6,552.25
1 The
hourly wage estimate is $28.89 based on the Occupational Employment and Wages, Mean Hourly Wage Rate for 21–1018 Substance
Abuse, Behavioral Disorder, and Mental Health Counselors = $28.89/hr. as of May 2023 (https://www.bls.gov/oes/current/oes211018.htm.
Accessed on April 17, 2024.)
Send comments to the SAMHSA
Reports Clearance Officer, 5600 Fishers
Lane, Room 15E45, Rockville, Maryland
20857, OR email a copy to samhsapra@
samhsa.hhs.gov. Written comments
should be received by August 23, 2024.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024–13766 Filed 6–21–24; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
lotter on DSK11XQN23PROD with NOTICES1
Federal Emergency Management
Agency
[Docket ID FEMA–2024–0002; Internal
Agency Docket No. FEMA–B–2443]
Proposed Flood Hazard
Determinations
Federal Emergency
Management Agency, Department of
Homeland Security.
AGENCY:
VerDate Sep<11>2014
18:55 Jun 21, 2024
Jkt 262001
ACTION:
Notice.
Comments are requested on
proposed flood hazard determinations,
which may include additions or
modifications of any Base Flood
Elevation (BFE), base flood depth,
Special Flood Hazard Area (SFHA)
boundary or zone designation, or
regulatory floodway on the Flood
Insurance Rate Maps (FIRMs), and
where applicable, in the supporting
Flood Insurance Study (FIS) reports for
the communities listed in the table
below. The purpose of this notice is to
seek general information and comment
regarding the preliminary FIRM, and
where applicable, the FIS report that the
Federal Emergency Management Agency
(FEMA) has provided to the affected
communities. The FIRM and FIS report
are the basis of the floodplain
management measures that the
community is required either to adopt
or to show evidence of having in effect
in order to qualify or remain qualified
SUMMARY:
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
for participation in the National Flood
Insurance Program (NFIP).
DATES: Comments are to be submitted
on or before September 23, 2024.
ADDRESSES: The Preliminary FIRM, and
where applicable, the FIS report for
each community are available for
inspection at both the online location
https://hazards.fema.gov/femaportal/
prelimdownload and the respective
Community Map Repository address
listed in the tables below. Additionally,
the current effective FIRM and FIS
report for each community are
accessible online through the FEMA
Map Service Center at https://
msc.fema.gov for comparison.
You may submit comments, identified
by Docket No. FEMA–B–2443, to Rick
Sacbibit, Chief, Engineering Services
Branch, Federal Insurance and
Mitigation Administration, FEMA, 400
C Street SW, Washington, DC 20472,
(202) 646–7659, or (email)
patrick.sacbibit@fema.dhs.gov.
FOR FURTHER INFORMATION CONTACT: Rick
Sacbibit, Chief, Engineering Services
E:\FR\FM\24JNN1.SGM
24JNN1
]]>Agencies
[Federal Register Volume 89, Number 121 (Monday, June 24, 2024)]
[Notices]
[Pages 52483-52484]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13766]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed project
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer at (240) 276-0166.
Comments are invited on: (a) whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Project: State Opioid Response (SOR)/Tribal Opioid Response (TOR)
Program Instrument (OMB No. 0930-0384)--Revision
SAMHSA is requesting approval to modify its existing SOR/TOR
Program Instrument by (1) broadening language from `naloxone' to
`naloxone and other opioid overdose reversal medications' due to the
availability of new FDA-approved non-naloxone overdose reversal
medications; (2) broadening language from `fentanyl test strips' to
`drug checking technologies as directed by SAMHSA' due to the
availability of new drug checking technology, including test strips for
other emerging substances; (3) reducing the number of questions from 12
to 10 by combining four questions with similar themes into two
questions for clarity; (4) removing question 12 because it is comprised
of more than one question with several different ideas, making it
unsuited for this instrument; and (5) adding one question at the
request of Office of National Drug Control Policy (ONDCP)to collect
information on Congressionally mandated and programmatic activities and
comply with reporting requirements. The program-level information is
collected quarterly and entered and stored in SAMHSA's Performance
Accountability and Reporting System, which is a real-time, performance
management system that captures information on SAMHSA funded substance
use and substance use disorder prevention, harm reduction, treatment,
and recovery support services, and mental health services delivered in
the United States. Continued approval of this information collection
will allow SAMHSA to continue to meet Government Performance and
Results Modernization Act (GPRA) of 2010 reporting requirements that
quantify the effects and accomplishments of its discretionary grant
programs.
The SOR/TOR programs are authorized under the Consolidated
Appropriations Act, 2023, Division H, Title II [Pub. L. 117-328], and
section 1003 of the 21st Century Cures Act [Pub. L. 114-255] (42 U.S.C.
290ee-3a), as amended. SOR/TOR programs aim to address the opioid
crisis by increasing access to FDA-approved medications for the
treatment of opioid use disorder (MOUD), and support the continuum of
prevention, harm reduction, treatment, and recovery support services
for opioid use disorder (OUD) and other concurrent substance use
disorders. The SOR program also supports the continuum of care for
stimulant misuse and use disorders, including for cocaine and
methamphetamine.
SAMHSA is proposing to revise the SOR/TOR Program Instrument data
collection instrument (OMB No. 0930-0384), to collect information on
Congressionally mandated and programmatic activities and comply with
reporting requirements.
SAMHSA developed the SOR/TOR Program Instrument to collect minimum
data on naloxone purchase and distribution, but the SOR/TOR programs
are unique in that they have prevention, education, and harm reduction
requirements. SOR/TOR grantees are required to engage in the following
prevention and education activities: (1) train peers, first responders,
and other key community sectors on recognition of opioid overdose and
appropriate use of the opioid overdose antidote naloxone; (2) develop
evidence-based community prevention efforts such as strategic messaging
on the consequences of opioid and stimulant misuse; (3) implement
school-based prevention programs and outreach; and (4) purchase and
distribute opioid overdose antidote reversal naloxone based on the
[[Page 52484]]
naloxone distribution and saturation plan, and train on its use. The
revised tool will continue to allow SAMHSA to collect data on the
required education and prevention activities, and better assess grantee
performance on these activities. The revisions will continue to assist
SAMHSA in providing comprehensive data on the full range of required
activities to inform Congressionally mandated reports for the SOR
program.
In order to address these issues, SAMHSA is proposing to (1)
broaden language from `naloxone' to `naloxone and other opioid overdose
reversal medications' due to the availability of new FDA-approved non-
naloxone overdose reversal medications; (2) broaden language from
`fentanyl test strips' to `drug checking technologies as directed by
SAMHSA' due to the availability of new drug checking technology,
including test strips for other emerging substances; (3) reduce the
number of questions from 12 to 10 by combining four questions with
similar themes into two questions for clarity; (4) remove question 12
because it is comprised of more than one question with several
different ideas, making it unsuited for this instrument; and (5) add
one question at the request of ONDCP to collect information on
Congressionally mandated and programmatic activities and comply with
reporting requirements.
A summary of the proposed changes includes:
Broadening the language to include new medications and
technologies that will provide SAMHSA data on the following:
[cir] Purchase and distribution of naloxone and other opioid
overdose reversal medications; and
[cir] Purchase and distribution of drug checking technologies as
directed by SAMHSA.
The revised tool will provide SAMHSA with clarification on
individuals recognizing an opioid overdose and appropriate use of
naloxone and other opioid overdose reversal medication by collapsing
two questions with a similar theme.
The revised tool will provide SAMHSA with clarification on
individuals educated on the consequences of opioid and/or stimulant
misuse by collapsing two questions with a similar theme.
One question will be added to provide data on the
following:
[cir] Types of entities that distribute naloxone and other opioid
overdose reversal medications.
The Center for Substance Abuse Treatment (CSAT) anticipates that
the time required to collect and report the program-level information
is approximately 18 minutes per response. Since the submission of the
previous OMB package, there has been an increase in the number of
respondents. The estimated burden associated with the program-level
instrument includes an adjustment to reflect the current number of
grantees.
Table 1--Estimate of Annualized Hour Burden for SOR/TOR Grantees
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Burden hours Total burden Hourly wage Total wage
SAMHSA data collection respondents respondent of responses per response hours \1\ cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
Grantee-Level Instrument................ 189 4 756 .30 226.80 $28.89 $6,552.25
---------------------------------------------------------------------------------------------------------------
CSAT Total.......................... 189 4 756 .30 226.80 28.89 6,552.25
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ The hourly wage estimate is $28.89 based on the Occupational Employment and Wages, Mean Hourly Wage Rate for 21-1018 Substance Abuse, Behavioral
Disorder, and Mental Health Counselors = $28.89/hr. as of May 2023 (https://www.bls.gov/oes/current/oes211018.htm. Accessed on April 17, 2024.)
Send comments to the SAMHSA Reports Clearance Officer, 5600 Fishers
Lane, Room 15E45, Rockville, Maryland 20857, OR email a copy to
[email protected]. Written comments should be received by August
23, 2024.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024-13766 Filed 6-21-24; 8:45 am]
BILLING CODE 4162-20-P
